Greenwich LifeSciences Income Statement (2019-2026) | GLSI

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
12.92M12.99M13.15M12.95M12.77M12.85M12.85M12.85M12.85M12.85M12.85M12.88M13.07M13.14M13.15M13.19M13.47M13.79M14.30M14.67M
Operating items
Research & Development (Quarter)
0.56M0.66M2.06M1.66M0.63M1.72M2.46M1.83M1.38M2.16M2.33M2.19M2.31M2.29M8.69M2.27M3.42M3.27M8.27M5.21M
Selling, General & Administrative (Quarter)
0.20M0.21M0.31M0.33M0.14M0.66M0.44M0.41M0.37M0.34M0.50M0.34M0.35M0.44M1.02M0.50M0.35M0.47M0.91M0.52M
Operating Expenses (Quarter)
0.75M0.87M2.38M1.99M0.77M2.38M2.89M2.24M1.75M2.50M2.84M2.54M2.66M2.73M9.71M2.77M3.77M3.73M9.18M5.73M
Operating Income (Quarter)
-0.75M-0.87M-2.38M-1.99M-0.77M-2.38M-2.89M-2.24M-1.75M-2.50M-2.84M-2.54M-2.66M-2.73M-9.71M-3.28M-4.05M-4.17M-7.94M-5.73M
EBIT (Quarter)
-0.75M-0.87M-2.38M-1.99M-0.77M-2.38M-2.89M-2.24M-1.75M-2.50M-2.84M-2.54M-2.66M-2.73M-9.71M-3.28M-4.05M-4.17M-7.94M-5.73M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.00M0.02M0.02M0.03M0.06M0.10M0.12M0.12M0.11M0.09M0.06M0.05M0.06M0.04M0.02M0.02M0.02M0.02M0.07M
Net income details
EBT (Quarter)
-0.75M-0.86M-3.87M-3.65M-2.59M-4.33M-5.93M-2.12M-1.63M-2.39M-7.25M-2.47M-2.61M-2.67M-16.30M-3.26M-4.03M-4.15M-17.20M-5.66M
Profit After Tax (Quarter)
-0.75M-0.86M-2.36M-1.97M-0.75M-2.32M-2.79M-2.12M-1.63M-2.39M-2.75M-2.47M-2.61M-2.67M-9.67M-2.74M-3.75M-3.71M-9.15M-5.66M
Income from Continuing Operations (Quarter)
-0.75M-0.86M-3.87M-3.65M-2.59M-4.33M-5.93M-2.12M-1.63M-2.39M-7.25M-2.47M-2.61M-2.67M-16.30M-3.26M-4.03M-4.15M-17.20M-5.66M
Consolidated Net Income (Quarter)
-0.75M-0.86M-3.87M-3.65M-2.59M-4.33M-5.93M-2.12M-1.63M-2.39M-7.25M-2.47M-2.61M-2.67M-16.30M-3.26M-4.03M-4.15M-17.20M-5.66M
Income towards Parent Company (Quarter)
-0.75M-0.86M-3.87M-3.65M-2.59M-4.33M-5.93M-2.12M-1.63M-2.39M-7.25M-2.47M-2.61M-2.67M-16.30M-3.26M-4.03M-4.15M-17.20M-5.66M
Net Income towards Common Stockholders (Quarter)
-0.75M-0.86M-3.87M-1.97M-0.75M-2.32M-5.93M-2.12M-1.63M-2.39M-7.25M-2.47M-2.61M-2.67M-16.30M-3.26M-4.03M-4.15M-17.20M-5.66M
Additional items
EPS (Basic) (Quarter)
-0.06-0.07-0.30-0.15-0.06-0.18-0.46-0.17-0.13-0.19-0.56-0.19-0.20-0.20-1.25-0.25-0.30-0.30-1.27-0.42
EPS (Diluted) (Quarter)
-0.06-0.18-0.46-0.17-0.13-0.19-0.56-0.19-0.20-0.20-1.25-0.25-0.30-0.30-1.27-0.42
Shares Outstanding (Quarter)
12.90M12.97M12.94M13.06M12.92M12.82M12.91M12.85M12.85M12.85M12.85M12.86M12.91M13.14M13.01M13.17M13.37M13.64M13.53M13.53M
Shares Outstanding (Diluted) (Quarter)
12.92M12.82M12.91M12.85M12.85M12.85M12.85M12.86M12.91M13.14M13.01M13.17M13.37M13.64M13.53M13.53M
EBITDA (Quarter)
-0.75M-0.87M-2.38M-1.99M-0.77M-2.38M-2.89M-2.24M-1.75M-2.50M-2.84M-2.54M-2.66M-2.73M-9.71M-3.28M-4.05M-4.17M-7.94M-5.73M
Interest Expenses (Quarter)
1.51M1.68M1.84M2.01M3.14M4.51M6.64M9.28M